InspireMD Inc-US Cguard Prime carotid stent system is expected to be commercialized in the first half of 2025 if approved
InspireMD Inc-美国如果获得批准Cguard Prime 颈动脉支架系统预计将于2025年上半年商用
InspireMD Inc-US Cguard Prime carotid stent system is expected to be commercialized in the first half of 2025 if approved
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.